AstraZeneca (AZN) CFO Dr. Aradhana Sarin joins Nicole Petallides to give an overview of the company and discuss its most recent earnings. AZN’s 3Q adjusted EPS came in at $0.86 versus an estimated $0.80 and revenue came in at $11.49B versus an estimated $11.44B. Sarin discusses AZN’s recent pipeline momentum. AMZN’s FY23 guidance sees core EPS increasing by low double-digit to low-teens percentage. Tune in to find out more about the stock market today.
Trading 360
09 Nov 2023
SHARE
Morning Trade Live
29 Feb 2024
Market On Close
30 Jan 2024
The Watch List
02 Feb 2024
The Watch List
05 Mar 2024
Morning Trade Live
11 Mar 2024
Morning Trade Live
15 Apr 2024